Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
MARKETS
Why Durata Therapeutics (DRTX) Stock Hit a One-Year High Today
By Andrew Meola
Oct 6, 2014 10:20 AM EDT
INVESTING
5 Stocks Moving on Unusual Volume
By Roberto Pedone
Aug 19, 2014 7:00 AM EDT
STOCKS
2014 FDA Drug Approval Calendar
By Adam Feuerstein
May 12, 2014 9:22 AM EDT
OPINION
Emerging 'Superbugs' -- and Why Investors Should Care
By Austin Dosch
Apr 21, 2014 12:23 PM EDT
INVESTING
A Busy Calendar of March Biotech Events
By Adam Feuerstein
Mar 3, 2014 1:13 PM EST
STOCKS
2014 FDA Drug Approval Decision Calendar
By Adam Feuerstein
Nov 27, 2013 8:00 AM EST
JIM CRAMER
Jim Cramer's 'Mad Money' Recap: Next Week's Game Plan
By Scott Rutt
Nov 22, 2013 8:05 PM EST
INVESTING
5 Stocks Poised for Big Breakouts
By Roberto Pedone
Jul 19, 2013 12:38 PM EDT
INVESTING
5 Stocks Poised for Breakouts
By Roberto Pedone
Mar 15, 2013 1:40 PM EDT
VIDEO
Take a Trip With Kayak, Skip Durata
By Debra Borchardt
Jul 18, 2012 5:30 AM EDT